Bayer Buys Merck Consumer Biz, Aiming For Top Of Global OTC Industry
This article was originally published in The Rose Sheet
Executive Summary
The $14.2 billion deal is “a major milestone on our path toward global leadership” in OTC sales, says Bayer Chairman Marijn Dekkers. The acquisition focuses on expanding international sales of Merck products including the Coppertone sunscreen, Claritin allergy and MiraLax constipation lines.
You may also be interested in...
Coppertone Sunscreens SPF At Half Of Label Level, Class Actions Allege
Proposed class action cases filed against Coppertone marketer Bayer and the brand's former owner, Merck & Co., federal and state courts allege two SPF 30 formulas contain half the SPF as advertised. The complaints continue a trend of class actions filed due to sunscreen claims criticized by Consumer Reports.
Coppertone Sunscreens SPF At Half Of Label Level, Class Action Complaints Allege
Proposed class action cases filed against Coppertone marketer Bayer and the brand's former owner, Merck & Co., federal and state courts allege two SPF 30 formulas contain half the SPF as advertised. The complaints continue a trend of class actions filed due to sunscreen claims criticized by Consumer Reports.
Coppertone Sunscreens SPF At Half Of Label Level, Class Action Complaints Allege
Proposed class action cases filed against Coppertone marketer Bayer and the brand's former owner, Merck & Co., federal and state courts allege two SPF 30 formulas contain half the SPF as advertised. The complaints continue a trend of class actions filed due to sunscreen claims criticized by Consumer Reports.